Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Doseology Sciences Inc. (C:MOOD)

Business Focus: Pharmaceuticals (NEC)

Sector:  Healthcare Industry:  Pharmaceuticals
 
Company Contact
Address: Suite 305, 9-3151 Lakeshore Rd
KELOWNA BC V1W 3S9
Tel: N/A
Website: https://doseology.com
IR: See website
Key People
Richard D. Nanula
Executive Chairman of the Board, Chief Executive Officer
Brian Zasitko
Chief Financial Officer
Assad J. Kazeminy
Chief Scientific Officer
Business Overview
Doseology Sciences Inc. is a Canada-based company, which is engaged in improving overall health with a focus on mental health through research, development, and sale of its branded functional mushroom products. The Company, along with its wholly owned subsidiary Dose Labs Inc., is building a progressive brand focused on mental health and wellness through nutraceutical products. The Company's functional mushroom products, including tinctures, powders, and supplements, are available on doseology.com and throughout various retail chains across Canada. Its products include Wake, Lion's Mane & Yerba Mate Tincture; Elevate, Lion's Mane & Ginger Tincture; Sleep, Reishi & Chamomile Tincture; Boost, Shiitake & Turmeric Tincture; Zenergy Bundle, and Mind, Mood & Body Bundle.
Financial Overview
For the six months ended 31 December 2023, Doseology Sciences Inc revenues increased from C$22K to C$59K. Net loss decreased 64% to C$190K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Salaries and benefits decrease of 84% to C$30K (expense), Management fees decrease from C$68K (expense) to C$0K, Professional fees decrease of 82% to C$9K (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $0.29M as of Dec 31, 2023
Annual revenue (TTM): $0.08M as of Dec 31, 2023
EBITDA (TTM): -$0.50M as of Dec 31, 2023
Net annual income (TTM): -$1.45M as of Dec 31, 2023
Free cash flow (TTM): -$0.42M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 4,400,515 as of Feb 16, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization